News
Novonix (ASX: NVX) powering the renewable futures needs
Last Wednesday at our weekly ‘Meet The CEOs’ briefing we were joined by Dr Chris Burns from Novonix Limited (ASX: NVX). Novonix is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry. They have operations in the USA and Canada and sales in over 14 countries.
Economic uncertainty is a favourable market condition for Credit Intelligence
Credit Intelligence (CI1) is an ASX-listed fintech company experiencing tailwinds amidst the economic uncertainty of COVID-19 and a long-awaited market correction.
Rhinomed’s step ladder in competitive US pharmacy sector
Rhinomed (ASX: RNO) radically improves the way people breathe, sleep, maintain their health and take medication. The company produces a wearable nasal stent platform that reduces snoring, increases air intake and relieves congestion and allergies through essential oil formulations.
Manuka Resources IPO for gold and silver prospects
Manuka Resources, the nation’s newest gold and silver producer, has launched its IPO. The company is looking to raise between $5 to $7 million to explore and mine highly prospective tenements across its two sites in the Cobar Basin, Central NSW.
Spirit Telecom grows 146% during COVID
Despite the tumultuous market and economic recession, ASX-listed Spirit Telecom (ASX: ST1) grew 146% in the four months January to April, compared to the prior corresponding period.
Neuroscientific Biopharmaceuticals positioned for Alzheimer’s breakthrough
Conditions like dementia and Alzheimer’s disease have the most likelihood of a medical breakthrough in the next 10 years. However, at present, there are few effective treatment options. For ASX-listed Neuroscientific Biopharmaceuticals (NSB), this is a focus area that shows great commercial promise and opportunity to improve patient outcomes.
Is the rally just a dead cat bounce? No one can know for sure – but that’s not necessarily a bad thing
The market’s recent gains have come largely from retail investors entering the market but not everyone is convinced that this rally is real. Magellan Co-founder defended his 46% cash position this week and many others are publicly voicing concerns that the market rally is just a dead cat bounce.
Prescient Therapeutics quantum leap in cancer treatment
Cancer treatments are changing and Prescient Therapeutics (ASX: PTX) is an Australian biotech company that is leading the way. Prescient’s PTX 100 and PTX 200 therapies have had compelling results in human clinical trials.
DXN Limited speeds up Internet infrastructure
DXN Limited (DXN) is an Australian small cap listed data centre company that is accelerating the shift to edge computing. Any information you access on the Internet goes through a data centre somewhere in the world. In the past decade or so, most data has been stored on cloud-based servers in dispersed locations.
Identitii – A global network for financial information
John Rayment, the CEO of Identitii (ID8: ASX), sat down with us last week for a special live investor briefing. He provided an update on the company, how the company can assist with the inaccuracies of information needed to process and report on financial transactions when incomplete or even missing, and why he believes Identitii is a good investment.
DXN’s Edge data centres are changing the data storage game
From Netflix’s database to every file on the cloud, most data is stored in warehouse-sized data centres owned by tech giants like Google and Amazon. While these warehouse-sized data centres might cater just fine to the casual Internet user’s needs, they can’t offer the high speed and reliability that businesses need to successfully automate and control critical infrastructure.
As payroll gets more complicated, PayGroup offers a SaaS solution
PayGroup is a payroll and human management SaaS company that simplifies payroll for companies dealing with complicated legislation.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.